Sanofi's strategy head to retire by month end, as company gears up for December strategic update

Natalie Grover

Reporter

While speculation that Sanofi is considering options for its consumer healthcare unit erupts ahead of a planned strategic update next month, it looks like …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sanofi's strategy head to retire by month end, as company gears up for December strategic update

Natalie Grover

Reporter

Sign up to read this article for free.

CEO of UnitedHealth insurance unit shot and killed in New York

Lilly beats Novo in bellwether head-to-head weight loss study

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

Lilly drops body mass ranges from FDA label for weight loss drug

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

Applied Therapeutics gets FDA warning letter over study of rejected rare disease drug

Sanofi's strat­e­gy head to re­tire by month end, as com­pa­ny gears up for De­cem­ber strate­gic up­date

Natalie Grover

Reporter

Sign up to read this article for free.

more like this

CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

On heels of Mar­i­Tide da­ta, Dan­ish obe­si­ty biotech dis­clos­es €80M Se­ries A

Ap­plied Ther­a­peu­tics gets FDA warn­ing let­ter over study of re­ject­ed rare dis­ease drug

Sanofi's strategy head to retire by month end, as company gears up for December strategic update

CEO of UnitedHealth insurance unit shot and killed in New York

Lilly beats Novo in bellwether head-to-head weight loss study

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

Lilly drops body mass ranges from FDA label for weight loss drug

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

Applied Therapeutics gets FDA warning letter over study of rejected rare disease drug